1. Where are the immunotoxins in the clinic?

   • J. H. Beijnen

   Editorial Pages: 145 - 145

2. Vitamin E in extrapyramidal disorders

   • L. Bischot
   • G. Van den Brink
   • A. J. Porsius

   Editorial Pages: 146 - 150

3. Aminoglycoside monitoring in the once- or twice-daily era

   • R. Janknegt

   Articles Pages: 151 - 155

4. Pharmacy personnel and fever: A study on perception, self-care and information to customers

   • J. R. Eskerud
   • M. Andrew
   • E. -L. Toverud

   Articles Pages: 156 - 160

5. General practitioners and fever: a study on perception, self-care and advice to patients

   • J. R. Eskerud
   • A. Brodwall

   Articles Pages: 161 - 164

6. Probenecid inhibits the renal clearance and renal glucuronidation of nalidixic acid

   • T. B. Vree
   • M. Van den Biggelaar-Martea
   • Y. A. Hekster

   Case Reports Pages: 165 - 170

7. Drug utilization studies in pregnancy

   • Lolkje De Jong-Van den Berg

   OriginalPaper Pages: 171 - 172

8. Intramuscular and subcutaneous drug delivery: Encapsulation in liposomes and other methods to manipulate drug availability

   • F. Kadir

   OriginalPaper Pages: 173 - 175

9. The prescription drug history in pharmacoepidemiology

   • H. Petri

   OriginalPaper Pages: 176 - 177

10. A pharmacognostical study of hop,Humulus lupulus L

    • C. R. Langezaal

    OriginalPaper Pages: 178 - 179

11. Chemometrical aspects of quality in pharmaceutical technology

    • J. H. De Boer

    OriginalPaper Pages: 180 - 183

12. The use of hypoglycaemic and cardiovascular drugs in 582 patients with diabetes mellitus. Description and quality assessment

    • G. Van den Brink
    • R. R. H. Schwartzenberg
    • A. J. Porsius

    Erratum Pages: 184 - 184